Citrix Analyst: 'Near-Term Pain For Long-Term Gain'
Citrix Systems, Inc. (NASDAQ: CTXS) reported second-quarter results that fell notably short of the Street's estimates, but Wedbush says investors should accept "near-term pain for long-term gains."
The Analyst
Wedbush's Daniel Ives maintains a Neutral rating on Citrix Systems with a price target lowered from $100 to $95.
The Thesis
Citrix's transition to focus on a subscription model is progressing faster than expected across its major business units and this was evident in Wednesday's earnings report, Ives wrote in a note. Specifically, the company spent the past 18 months transitioning the company to better focus on cloud/subscription. During the second quarter management initially guided for cloud/subscription to represent 52% of the business but the actual number came in at 62%.
Ives said a shift towards a more visible business model is encouraging and the company deserves credit for its execution so far. In fact, the company offered a new metric ARR (annual recurring revenue), which will be a notable measure for the rest of 2019 and into next year to measure further improvements in the transition.
During the second quarter ARR was 33% higher year-over-year at $614 million and SaaS ARR was 50% higher year-over-year at $418 million.
Ives said investors with plenty of patience may benefit from Citrix's stock as "all the pieces are generally in place" for its cloud transition. However, the near-term picture is clouded with uncertainty in the field.
Price Action
Shares of Citrix were trading lower by more than 5% at $95.63 Thursday afternoon.
Related Links:
Citrix Systems Analysts Have Mixed Response To Q1 Print
Mid-Day Market Update: Dow Down 170 Points; Gemphire Therapeutics Shares Spike Higher
Latest Ratings for CTXS
Jul 2019 | Maintains | Underweight | ||
Jun 2019 | Upgrades | Hold | Buy | |
Jun 2019 | Upgrades | Hold | Buy |
View More Analyst Ratings for CTXS
View the Latest Analyst Ratings
See more from Benzinga
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
